Skip to content

The effect of stachys lavandulifolia extract on the symptoms of primary dysmenorrhea

A double blind, cross over, placebo controlled study of standardized hydro-alcoholic extract of stachys lavandulifolia on primary dysmenorrhea symptoms

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138904133106N2
Enrollment
30
Registered
2010-12-19
Start date
2010-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Placebo: In case of existence of dysmenorrheal pain, 24 hours before initiation of approximate cycle time till 48 hours after, patients should take 1 capsule and repeat it each 4-6 h
Placebo
Treatment - Drugs
Placebo: In case of existence of dysmenorrheal pain, 24 hours before initiation of approximate cycle time till 48 hours after, patients should take 1 capsule and repeat it each 4-6 hours if needed.
Herbal capsule: In case of existence of dysmenorrheal pain, 24 hours before initiation of approximate cycle time till 48 hours after, patients should take 1 capsule and repeat it each 4-6 hours if ne

Sponsors

Pharmaceutical science branch of Islamic Azad university
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : 1-age of 18-45 years, 2- diagnosis of primary dysmenorrheal, 3- existence of dysmenorrhrea in most of cycles. Exclusion criteria: 1-pregnancy, 2- lactation, 3-abnormal vaginal bleeding, 4-moderate to sever menorrhagia, 5-BMI more than 30, 6-OCP and other hormonal drugs consumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: at the end each cycle up to three cycles. Method of measurement: macgill pain questionnaire.;Severity of pain. Timepoint: at the end each cycle up to three cycles. Method of measurement: visual analogue scale (VAS).

Secondary

MeasureTime frame
Side effects. Timepoint: at the end each cycle up to three cycles. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026